# Expanded Access to ABBV-8E12

> **NCT03744546** · — · NO_LONGER_AVAILABLE · sponsor: **AbbVie**

## Conditions studied

- Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)

## Interventions

- **DRUG:** ABBV-8E12

## Key facts

- **NCT ID:** NCT03744546
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744546, "Expanded Access to ABBV-8E12". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03744546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*